GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioventix PLC (LSE:BVXP) » Definitions » Operating Cash Flow per Share

Bioventix (LSE:BVXP) Operating Cash Flow per Share : £1.51 (TTM As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Bioventix Operating Cash Flow per Share?

Bioventix's operating cash flow per share for the six months ended in Dec. 2023 was £0.83. Bioventix's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was £1.51.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Bioventix was -0.90% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 0.10% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 5.40% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 19.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Bioventix's Operating Cash Flow per Share or its related term are showing as below:

LSE:BVXP' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: 0.1   Med: 23.35   Max: 39.4
Current: 0.1

During the past 13 years, Bioventix's highest 3-Year average Operating Cash Flow per Share Growth Rate was 39.40% per year. The lowest was 0.10% per year. And the median was 23.35% per year.

LSE:BVXP's 3-Year OCF Growth Rate is ranked worse than
55.6% of 1241 companies
in the Biotechnology industry
Industry Median: 3.7 vs LSE:BVXP: 0.10

Bioventix Operating Cash Flow per Share Historical Data

The historical data trend for Bioventix's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioventix Operating Cash Flow per Share Chart

Bioventix Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.12 1.47 1.20 1.44 1.48

Bioventix Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.72 0.72 0.80 0.68 0.83

Competitive Comparison of Bioventix's Operating Cash Flow per Share

For the Biotechnology subindustry, Bioventix's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioventix's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioventix's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Bioventix's Price-to-Operating-Cash-Flow falls into.



Bioventix Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Bioventix's Operating Cash Flow per Share for the fiscal year that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (A: Jun. 2023 )=Cash Flow from Operations (A: Jun. 2023 )/Shares Outstanding (Diluted Average) (A: Jun. 2023 )
=7.802/5.290
=1.47

Bioventix's Operating Cash Flow per Share for the quarter that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )=Cash Flow from Operations (Q: Dec. 2023 )/Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
=4.4/5.297
=0.83

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £1.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioventix Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Bioventix's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioventix (LSE:BVXP) Business Description

Industry
Traded in Other Exchanges
Address
East Street, 7 Romans Business Park, Farnham, Surrey, GBR, GU9 7SX
Bioventix PLC is a biotechnology company based in the United Kingdom. It specializes in the creation and supply of high-affinity sheep monoclonal antibodies and clinical diagnostics and drug abuse testing. The company's portfolio of products includes drugs that are applicable in the areas of cardiology, fertility, infectious diseases, Thyroid, and vitamin D disorder among others.

Bioventix (LSE:BVXP) Headlines

No Headlines